102 results
S-8
EX-4.6
ARWR
Arrowhead Pharmaceuticals Inc.
28 Feb 24
Registration of securities for employees
5:25pm
or in combinations thereof) as deemed appropriate by the Administrator. A Performance Criterion and any targets with respect thereto determined
8-K
EX-99.1
ARWR
Arrowhead Pharmaceuticals Inc.
6 Feb 24
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
4:07pm
are on schedule for clinical trial application (CTA) filings before the end of 2024
◦ARO-INHBE utilizes the liver targeted TRiMTM platform and targets
424B5
r5cgo4wzq3ky9 hm2
4 Jan 24
Prospectus supplement for primary offering
5:01pm
S-3ASR
h6vznlc t0v
2 Dec 22
Automatic shelf registration
9:23pm
S-8
EX-4.4
y7o1o
18 May 21
Registration of securities for employees
4:11pm
S-8
EX-4.5
osw m3zgcu
18 May 21
Registration of securities for employees
4:11pm